Condition

Recurrent Mantle Cell Lymphoma (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

Intervention

bortezomib (1)

laboratory biomarker analysis (1)

lenalidomide (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

recurrent mantle cell lymphoma

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recurrent Mantle Cell Lymphoma Trial in United States (Bortezomib, Laboratory Biomarker Analysis, Lenalidomide)

Completed

Recurrent Mantle Cell Lymphoma

Bortezomib
+2 more

Anaheim, California
+81 more

Oct 2, 2018